FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics, and concerns treating placental insufficiency in trimester II-III of pregnancy. For this purpose, conventional therapy is complemented with oxygen therapy and foetal sex determination. Those pregnant women with a predicted female foetuses require therapeutic inhalations with mixed gas containing oxygen - 40%, atmospheric air - the rest at air flow 5-6 litres per minute, length of a session 30 min once a day, the therapeutic course 10 procedures, while those pregnant women carrying female foetuses require therapeutic inhalations with mixed gas containing oxygen - 60%, atmospheric air - the rest at air flow 5-6 litres per minute, length of a session 45 min once a day, the therapeutic course 15 procedures.
EFFECT: method provides effective treatment of placental insufficiency with reduced side effects ensured by dosed oxygen therapy shown by foetus sex determination test.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING THREATENED PREGNANCY | 2009 |
|
RU2417109C2 |
| METHOD OF TREATING FETOPLACENTAL INSUFFICIENCY IN PREGNANT WOMEN | 2010 |
|
RU2426521C1 |
| METHOD OF PREVENTING SEVERE FORMS OF OBSTETRICAL PATHOLOGY | 2010 |
|
RU2422149C1 |
| COMPOSITION AND METHOD FOR TREATMENT OF FETOPLACENTAL INSUFFICIENCY | 2006 |
|
RU2324486C2 |
| METHOD FOR PREDICTION OF PLACENTAL INSUFFICIENCY IN SECOND TRIMESTER OF PREGNANCY | 2014 |
|
RU2554827C1 |
| METHOD OF TREATING FETOPLACENTAL INSUFFICIENCE | 2008 |
|
RU2391104C1 |
| METHOD OF REMODELING OF THREATENED PRETERM LABOR | 2017 |
|
RU2647227C1 |
| METHOD FOR PREDICTION OF PREECLAMPSIA IN PREGNANT WOMEN WITH GESTATIONAL DIABETES MELLITUS | 2020 |
|
RU2740852C1 |
| METHOD OF TREATING THREATENED MISCARRIAGE IN EARLY PREGNANCY | 2009 |
|
RU2393841C1 |
| METHOD FOR EARLY PREDICTION OF PLACENTAL INSUFFICIENCY | 2009 |
|
RU2410030C1 |
